These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33353013)

  • 1. Biodegradable Nanoparticle for Cornea Drug Delivery: Focus Review.
    Mobaraki M; Soltani M; Zare Harofte S; L Zoudani E; Daliri R; Aghamirsalim M; Raahemifar K
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33353013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects.
    Durak S; Esmaeili Rad M; Alp Yetisgin A; Eda Sutova H; Kutlu O; Cetinel S; Zarrabi A
    Nanomaterials (Basel); 2020 Jun; 10(6):. PubMed ID: 32570885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
    Liu LC; Chen YH; Lu DW
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
    Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
    J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracorneal injection of a detachable hybrid microneedle for sustained drug delivery.
    Lee K; Song HB; Cho W; Kim JH; Kim JH; Ryu W
    Acta Biomater; 2018 Oct; 80():48-57. PubMed ID: 30267886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
    Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates on Biodegradable Formulations for Ocular Drug Delivery.
    Tsung TH; Chen YH; Lu DW
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical siRNA delivery to the cornea and anterior eye by hybrid silicon-lipid nanoparticles.
    Baran-Rachwalska P; Torabi-Pour N; Sutera FM; Ahmed M; Thomas K; Nesbit MA; Welsh M; Moore CBT; Saffie-Siebert SR
    J Control Release; 2020 Oct; 326():192-202. PubMed ID: 32653503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An insight on ophthalmic drug delivery systems: Focus on polymeric biomaterials-based carriers.
    Shafiq M; Rafique M; Cui Y; Pan L; Do CW; Ho EA
    J Control Release; 2023 Oct; 362():446-467. PubMed ID: 37640109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal dexamethasone-moxifloxacin nanoparticle combinations with collagen/gelatin/alginate hydrogel for corneal infection treatment and wound healing.
    Chang MC; Kuo YJ; Hung KH; Peng CL; Chen KY; Yeh LK
    Biomed Mater; 2020 Aug; 15(5):055022. PubMed ID: 32434164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical delivery of ocular therapeutics: carrier systems and physical methods.
    Souza JG; Dias K; Pereira TA; Bernardi DS; Lopez RF
    J Pharm Pharmacol; 2014 Apr; 66(4):507-30. PubMed ID: 24635555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
    Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
    J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of biomaterials in corneal wound healing.
    Tsai IL; Hsu CC; Hung KH; Chang CW; Cheng YH
    J Chin Med Assoc; 2015 Apr; 78(4):212-7. PubMed ID: 25455161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology-based formulations to amplify intraocular bioavailability.
    Kagkelaris K; Panayiotakopoulos G; Georgakopoulos CD
    Ther Adv Ophthalmol; 2022; 14():25158414221112356. PubMed ID: 35873277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
    Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye.
    Wang Y; Xu X; Gu Y; Cheng Y; Cao F
    Expert Opin Drug Deliv; 2018 Jul; 15(7):687-701. PubMed ID: 29985660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone-releasing hormone agonist and transferrin functionalizations enhance nanoparticle delivery in a novel bovine ex vivo eye model.
    Kompella UB; Sundaram S; Raghava S; Escobar ER
    Mol Vis; 2006 Oct; 12():1185-98. PubMed ID: 17102798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Drug Delivery Systems to Improve the Treatment of Keratitis.
    Polat HK; Kurt N; Aytekin E; Bozdağ Pehlivan S; Çalış S
    J Ocul Pharmacol Ther; 2022; 38(6):376-395. PubMed ID: 35763406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of nanomedicine targeting scar-forming myofibroblasts to attenuate corneal scarring and haze.
    Ibrahim Al-Mashahedah AM; Kanwar RK; Kanwar JR
    Nanomedicine (Lond); 2019 Apr; 14(8):1049-1072. PubMed ID: 30901304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.